- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imation begins shipping 8 x 10 DryView
Imation last week began commercial shipments of DryView 8300,the 8 x 10 version of its DryView dry-process laser printing technology.DryView 8300 is targeted at nuclear medicine, ultrasound, andsmall-format applications. Imation last month marked the
Imation last week began commercial shipments of DryView 8300,the 8 x 10 version of its DryView dry-process laser printing technology.DryView 8300 is targeted at nuclear medicine, ultrasound, andsmall-format applications.
Imation last month marked the 1000th installation of its 14x 17 DryView printer, DryView 8700. Imation donated the 1000thDryView 8700 to the Mayo Clinic Foundation in Rochester, MN. Asof October, Imation had sold 1500 DryView printers.
In other DryView news, Imation is planning to release an 11x 14 version of DryView. The new printer, to be called DryView8500, will be targeted at computed radiography applications, aswell as international markets, according to the company.
Imation last week released financial results for its thirdquarter (end-September) that indicated strong profit growth. Imationposted a profit of $11.8 million on revenues of $559.3 million.Revenues were up 2.4% compared with the same period last yearfor the 3M businesses that were later spun off to create Imation.The revenue growth was the first in 11 quarters for the businessunits, according to Imation chairman and CEO William Monahan.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
